COVID-19 in a High-Risk Dual Heart and Kidney Transplant Recipient.

AMERICAN JOURNAL OF TRANSPLANTATION(2020)

引用 45|浏览10
暂无评分
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly infecting people worldwide, resulting in the infectious disease coronavirus disease 19 (COVID-19) that has been declared a pandemic. Much remains unknown about COVID-19, including its effects on solid organ transplant (SOT) recipients. Given their immunosuppressed state, SOT recipients are presumed to be at high risk of complications with viral infections such as SARS-CoV-2. Limited case reports in single SOT recipients, however, have not suggested a particularly severe course in this population. In this report, we present a dual-organ (heart/kidney) transplant recipient who was found to have COVID-19 and, despite the presence of a number of risk factors for poor outcomes, had a relatively mild clinical course.
更多
查看译文
关键词
biomarker,clinical research,practice,diabetes,type 2,graft survival,heart transplantation,cardiology,immunosuppressive regimens - minimization,withdrawal,infection and infectious agents - viral,infectious disease,kidney transplantation,nephrology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要